You have 9 free searches left this month | for more free features.

semaglutide

Showing 1 - 25 of 191

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes Trial in Jinan (Semaglutide, Semaglutide Pen Injector [Ozempic])

Not yet recruiting
  • Type 2 Diabetes
  • Semaglutide
  • Semaglutide Pen Injector [Ozempic]
  • Jinan, Shandong, China
    Shandong Provincial Hospital
Jul 11, 2023

Semaglutide Use in Acute Pulmonary Embolism

Completed
  • Pulmonary Embolism
  • Semaglutide
  • London, United Kingdom
    Colm McCabe
Nov 3, 2023

Alcohol Use Disorder Trial in Tulsa (Semaglutide, Placebo)

Not yet recruiting
  • Alcohol Use Disorder
  • Semaglutide
  • Placebo
  • Tulsa, Oklahoma
    OSU Biomedical Imaging Center
Jun 5, 2023

Healthy Participants Trial in Neuss (Semaglutide)

Not yet recruiting
  • Healthy Participants
  • Semaglutide
  • Neuss, Germany
    Novo Nordisk Investigational Site
Aug 10, 2023

Non-alcoholic Steatohepatitis Trial in Montreal (NNC0194-0499, Semaglutide, NNC0194-0499/Semaglutide A (40/3.20 mg/mL))

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • Montreal, Quebec, Canada
    Novo Nordisk Investigational Site
Mar 9, 2023

Addiction, Alcohol Use Disorder Trial in Baltimore (Take Control, Semaglutide)

Recruiting
  • Addiction
  • Alcohol Use Disorder
  • Take Control
  • Semaglutide
  • Baltimore, Maryland
    National Institute on Drug Abuse
Sep 2, 2023

Diabetic Kidney Disease, Type 1 Diabetes Trial (Semaglutide, Placebo)

Not yet recruiting
  • Diabetic Kidney Disease
  • Type 1 Diabetes
  • Semaglutide
  • Placebo
  • (no location specified)
Apr 18, 2023

Cystic Fibrosis, Cystic Fibrosis-related Diabetes Trial in Minneapolis (Semaglutide)

Not yet recruiting
  • Cystic Fibrosis
  • Cystic Fibrosis-related Diabetes
  • Semaglutide
  • Minneapolis, Minnesota
    University of Minnesota
Mar 15, 2023

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese Trial (Semaglutide)

Not yet recruiting
  • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
  • Obese
  • Semaglutide
  • (no location specified)
Apr 6, 2023

Fibrosis, Liver, Type 2 Diabetes in Obese, Non-Alcoholic Fatty Liver Disease Trial in La Jolla (Semaglutide, Placebo)

Recruiting
  • Fibrosis, Liver
  • +2 more
  • Semaglutide
  • Placebo
  • La Jolla, California
    University of California, San Diego
Aug 25, 2023

Healthy Volunteers Trial in Berlin (Semaglutide, Dapagliflozin, Semaglutide/dapagliflozin)

Recruiting
  • Healthy Volunteers
  • Semaglutide
  • +2 more
  • Berlin, Brandenburg, Germany
    Novo Nordisk Investigational Site
Aug 10, 2022

ive Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Active, not recruiting
  • Diabetes
  • Semaglutide
  • DPP-4 inhibitor
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 3, 2023

Diabetes, Type 2 Trial in Austria, Denmark, Sweden (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Placebo (semaglutide)
  • Graz, Austria
  • +3 more
Dec 5, 2022

Healthy Volunteers, Diabetes, Type 2, Overweight Trial in Groningen (Semaglutide, Dulaglutide)

Completed
  • Healthy Volunteers
  • +3 more
  • Groningen, Netherlands
    Novo Nordisk Investigational Site
Nov 4, 2022

Diabetes, Type 2 Trial (Semaglutide, Empagliflozin)

Withdrawn
  • Diabetes Mellitus, Type 2
  • (no location specified)
Nov 11, 2022

Acute Ischemic Stroke Trial in Aarhus (Semaglutide, Standard care)

Not yet recruiting
  • Acute Ischemic Stroke
  • Semaglutide
  • Standard care
  • Aarhus, Denmark
    Aarhus University Hospital
Dec 9, 2022

Type 2 Diabetes, End Stage Renal Disease on Dialysis Trial in Chapel Hill (Semaglutide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • End Stage Renal Disease on Dialysis
  • Semaglutide
  • Placebo
  • Chapel Hill, North Carolina
    University of North Carolina
Sep 11, 2023

Healthy Participants Trial in Montreal (Semaglutide)

Recruiting
  • Healthy Participants
  • Semaglutide
  • Montreal, Quebec, Canada
    Novo Nordisk Investigational Site
Oct 18, 2023

Healthy, Obesity Trial (BI 1820237, semaglutide, Placebo)

Not yet recruiting
  • Healthy
  • Obesity
  • BI 1820237
  • +3 more
  • (no location specified)
Mar 6, 2023

Overweight, Obesity Trial in China (Semaglutide, Semaglutide Placebo)

Not yet recruiting
  • Overweight
  • Obesity
  • Semaglutide
  • Semaglutide Placebo
  • Beijing, Beijing, China
  • +14 more
May 26, 2023

Alzheimer, Mild Cognitive Impairment, Metabolic Syndrome Trial in Ramat Gan (Semaglutide, Intranasal insulin, Semaglutide )

Not yet recruiting
  • Alzheimer Disease
  • +2 more
  • Semaglutide
  • +3 more
  • Ramat Gan, Israel
    Joseph Sagol Neuroscience center, Sheba Medical Center
Oct 3, 2023

Cardiomyopathy, Heart Failure With Preserved Ejection Fraction (HFpEF), Obesity Trial in Rochester (Semaglutide, Placebo,

Recruiting
  • Cardiomyopathy
  • +2 more
  • Semaglutide
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 3, 2023

Diabetes, Type 2 Trial in Beijing (NNC0480 0389, Semaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • NNC0480 0389
  • Semaglutide
  • Beijing, Beijing, China
    Novo Nordisk Investigational Site
Aug 11, 2022

Diabetes, Type 2 Trial in Santiago, Región Metropolitana (Semaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Santiago, Región Metropolitana, Chile
  • +2 more
Sep 9, 2022

Diabetes, Type 2 Trial (Semaglutide, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Placebo
  • (no location specified)
Jul 31, 2022